Institute for OneWorld Health Awarded $46 Million Grant to Combat Diarrheal Disease
The Institute for OneWorld Health (iOWH) announced that it has been awarded a grant of $46 million from the Bill & Melinda Gates Foundation to continue and expand its unique research on new treatments to complement traditional approaches in fighting diarrhea. The announcement came at Forum 10, the Global Forum for Health Research’s annual meeting underway in Cairo, Egypt. Diarrheal diseases are a leading cause of death in children under the age of five worldwide, killing more than 2 million children and contributing to the deaths of 4 million children each year. Diarrheal diseases are caused by a wide range of bacterial, parasitic, and viral pathogens, some of which result in rapid fluid loss, and can lead to severe dehydration and death. Read the full release.

Institute for OneWorld Health will be Hosting Two Symposia at the 55th Annual ASTMH Meeting at the Atlanta Marquis Marriott in Atlanta, Georgia Nov 12-16, 2006

On Wednesday, Nov 15, 2006 the Institute for OneWorld Health will be hosting a symposium titled Getting In-Zinc: A discussion of zinc supplementation to combat diarrheal and other infectious diseases moderated by Susan Wilson, PhD of the Institute for OneWorld Health. Later that day we will be hosting a second symposium titled Three complementary approaches to meet the challenges of the artemisinin supply chain moderated by Thomas Brewer, MD, FACP of the Bill and Melinda Gates Foundation.

On Wednesday, Nov 15, 2006 the Institute for OneWorld Health will be hosting a symposium titled Getting In-Zinc: A discussion of zinc supplementation to combat diarrheal and other infectious diseases with Panelists W. Abdullah Brooks of ICDDR,B, Henry Binder of Yale University School of Medicine, Shinjini Bhatnagar of All India Institute of Medical Sciences, and Peter John Winch from Johns Hopkins Bloomberg School of Public Health. The symposium will be moderated by Susan Wilson of the Institute for OneWorld Health.

Zinc supplementation is a powerful therapeutic tool in managing a long list of illnesses, including infectious diseases such as pneumonia, diarrhea and malaria. This symposium will bring together researchers and clinicians to discuss the use of zinc in regions throughout the world and its effects on the clinical course of infectious diseases. The experts will also address the use of zinc in conjunction with therapies such as ORS, and how these tools can be successful on a global level.

Later that day we will be hosting a second symposium titled three complementary approaches to meet the challenges of the artemisinin supply chain with panelists: J. Carl Craft from Medicines for Malaria Venture, Dianna Bowles of the University of York and Victoria Hale from the Institute for OneWorld Health. The panel will be moderated by Thomas Brewer of the Bill and Melinda Gates Foundation and will

To address the challenges of artemisinin derivatives manufacturing and supply, many different and complementary approaches are being pursued. The Medicines for Malaria Venture, the University of York/Center for Novel Agricultural Products consortium and the Institute for OneWorld Health will present their unique strategies and will discuss the forecasted impact of their approaches within the context of the global fight against malaria.

For more information about ASTMH visit their website.


The Institute for One World Health has been featured extensively in the news recently in publications ranging from Forbes to Philanthropy Roundtable magazine. Visit our website to read these and other articles including "Bets on Biotech" published in US News & World Report in September.

The Institute for OneWorld Health depends on the generous support of individuals all over the world to fulfill our mission. Thank you for supporting our work and helping us to develop and provide access to safe, effective, and affordable medicines for people with neglected diseases in the developing world.

Please consider going to our website now and making a contribution, or calling us at 415.421.4700 for further information.

The Institute for One World Health is growing and searching for passionate and talented industry professionals to help us fulfill our mission of developing safe, effective, and affordable new medicines for people with diseases of poverty in the developing world.

For a current listing of open positions in our San Francisco office please visit the employment page on our website.

back to top >